Inventor · disambiguated record
Adrian M. Timmers
Also filed as: TIMMERS ADRIAN · TIMMERS ADRIAN M
5 granted patents·12 pending applications·0 citations·filing 2008–2025
67Inventor score
Files withALCON RES LTD6LILLY CO ELI3APPLIED GENETIC TECH CORPORATION2ARROWHEAD RES CORP2CHATTERTON JON E2
Top patents by PatentIndex Score
17 records- 0166US9139834B2RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesisARROWHEAD RES CORP·Filed 2014·Granted Sep 22, 2015·0 cites·17 claims
- 0266US2009036397A1RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMAALCON RES LTD·Filed 2008·Application pending·0 cites
- 0366US2009036396A1RNAi-RELATED INHIBITION OF TNFalpha SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESISALCON RES LTD·Filed 2008·Application pending·0 cites
- 0464US2024318199A1Adeno-associated virus (aav) systems for treatment of progranulin associated neurodegenerative diseases or disordersBEACON THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0561US2009035225A1RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMAALCON RES LTD·Filed 2008·Application pending·0 cites
- 0660US9422556B2RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesisARROWHEAD RES CORP·Filed 2015·Granted Aug 23, 2016·0 cites·16 claims
- 0760US8754202B2RNAi-related inhibition of TNFα signaling pathway for treatment of ocular angiogenesisCHATTERTON JON E·Filed 2011·Granted Jun 17, 2014·0 cites·1 claims
- 0860US2016326533A1RNAi-Related Inhibition of TNF-alpha Signaling Pathway for Treatment of Ocular AngiogenesisARROWHEAD PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0957US12241077B2Adeno-associated virus (AAV) systems for treatment of genetic hearing lossLILLY CO ELI·Filed 2020·Granted Mar 4, 2025·0 cites·18 claims
- 1057US2011190376A1RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMAALCON RES LTD·Filed 2011·Application pending·0 cites
- 1157US2015057336A1RNAi-RELATED INHIBITION OF TNF alpha SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMAALCON RES LTD·Filed 2014·Application pending·0 cites
- 1256US2024226330A9Variant adeno-associated virus (aav) capsid polypeptides and gene therapeutics thereof for treatment of hearing lossLILLY CO ELI·Filed 2023·Application pending·0 cites
- 1355US2010267811A1RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESISALCON RES LTD·Filed 2010·Application pending·0 cites
- 1453US8865670B2RNAi-related inhibition of TNFα signaling pathway for treatment of glaucomaCHATTERTON JON E·Filed 2011·Granted Oct 21, 2014·0 cites·14 claims
- 1551US2025236887A1Adeno-associated virus (aav) systems for treatment of genetic hearing lossLILLY CO ELI·Filed 2025·Application pending·0 cites
- 1650US2021147872A1Adeno-associated virus (aav) systems for treatment of progranulin associated neurodegenerative diseases or disordersAPPLIED GENETIC TECH CORPORATION·Filed 2020·Application pending·0 cites
- 1741US2021123076A1Adeno-associated virus (aav)vectors for the treatment of age-related macular degeneration and other ocular diseases and disordersAPPLIED GENETIC TECH CORPORATION·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Adrian M. Timmers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →